174 related articles for article (PubMed ID: 3022916)
41. Rationally designed analogues of tamoxifen with improved calmodulin antagonism.
Hardcastle IR; Rowlands MG; Houghton J; Parr IB; Potter GA; Jarman M; Edwards KJ; Laughton CA; Trent JO; Neidle S
J Med Chem; 1995 Jan; 38(2):241-8. PubMed ID: 7830266
[TBL] [Abstract][Full Text] [Related]
42. Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen.
Horwitz KB; Koseki Y; McGuire WL
Endocrinology; 1978 Nov; 103(5):1742-51. PubMed ID: 748014
[TBL] [Abstract][Full Text] [Related]
43. Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells.
Coradini D; Biffi A; Cappelletti V; Di Fronzo G
Anticancer Res; 1994; 14(3A):1059-64. PubMed ID: 8074450
[TBL] [Abstract][Full Text] [Related]
44. Induction of myeloid differentiation of HL-60 cells with naphthalene sulfonamide calmodulin antagonists.
Veigl ML; Sedwick WD; Niedel J; Branch ME
Cancer Res; 1986 May; 46(5):2300-5. PubMed ID: 3008985
[TBL] [Abstract][Full Text] [Related]
45. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
Bouhoute A; Leclercq G
Biochem Biophys Res Commun; 1992 May; 184(3):1432-40. PubMed ID: 1590802
[TBL] [Abstract][Full Text] [Related]
46. Nonsteroidal antiestrogen inhibition of protein kinase C in human corpus luteum and placenta.
Eyster KM; Clark MR
Biochem Pharmacol; 1989 Oct; 38(20):3497-503. PubMed ID: 2818641
[TBL] [Abstract][Full Text] [Related]
47. Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation.
Brandes LJ; Gerrard JM; Bogdanovic RP; Lint DW; Reid RE; LaBella FS
Cancer Res; 1988 Jul; 48(14):3954-8. PubMed ID: 3164253
[TBL] [Abstract][Full Text] [Related]
48. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
49. Opposite regulation of cAMP concentration in the quail oviduct and the mouse uterus by tamoxifen. Correlation with estrogen-antagonist and estrogen-agonist activity.
Fanidi A; Ahnadi C; Fayard JM; Pageaux JF; Laugier C
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):571-7. PubMed ID: 1314079
[TBL] [Abstract][Full Text] [Related]
50. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
Sheen YY; Simpson DM; Katzenellenbogen BS
Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
[TBL] [Abstract][Full Text] [Related]
51. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
[TBL] [Abstract][Full Text] [Related]
52. Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells.
Cover CM; Hsieh SJ; Cram EJ; Hong C; Riby JE; Bjeldanes LF; Firestone GL
Cancer Res; 1999 Mar; 59(6):1244-51. PubMed ID: 10096555
[TBL] [Abstract][Full Text] [Related]
53. Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells.
McClay EF; Albright KD; Jones JA; Christen RD; Howell SB
Cancer Res; 1993 Apr; 53(7):1571-6. PubMed ID: 8453625
[TBL] [Abstract][Full Text] [Related]
54. Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer.
Edwards DP; Murthy SR; McGuire WL
Cancer Res; 1980 May; 40(5):1722-6. PubMed ID: 7371001
[TBL] [Abstract][Full Text] [Related]
55. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
Zhang L; Kharbanda S; Hanfelt J; Kern FG
Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
[TBL] [Abstract][Full Text] [Related]
56. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
Kijima I; Itoh T; Chen S
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
[TBL] [Abstract][Full Text] [Related]
57. [Mechanism of action of a triphenylethylene type antiestrogen on growth of the human breast cancer cell line. MCF-7 in culture].
Jozan S; Elalamy H; Bayard F
C R Seances Acad Sci III; 1981 Mar; 292(12):767-70. PubMed ID: 6788395
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.
Gottardis MM; Jiang SY; Jeng MH; Jordan VC
Cancer Res; 1989 Aug; 49(15):4090-3. PubMed ID: 2743303
[TBL] [Abstract][Full Text] [Related]
59. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
Gong Y; Ballejo G; Murphy LC; Murphy LJ
Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
[TBL] [Abstract][Full Text] [Related]
60. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.
Vickers PJ; Dickson RB; Shoemaker R; Cowan KH
Mol Endocrinol; 1988 Oct; 2(10):886-92. PubMed ID: 3185565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
